Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.4.0.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Statement of Cash Flows [Abstract]    
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES $ 337 $ (1,392)
INVESTING ACTIVITIES    
Purchase of medical equipment and property (3,274) (3,670)
Proceeds from sale of medical equipment and property 884 1,118
NET CASH USED IN INVESTING ACTIVITIES (2,390) (2,552)
FINANCING ACTIVITIES    
Principal payments on revolving credit facility, term loans and capital lease obligations (15,369) (39,180)
Cash proceeds from revolving credit facility 17,081 45,980
Debt issuance costs   (147)
Common stock repurchased to satisfy statutory withholding on employee stock based compensation plans (33)  
Cash proceeds from stock plans 125  
NET CASH PROVIDED BY FINANCING ACTIVITIES 1,804 6,653
Net change in cash and cash equivalents (249) 2,709
Cash and cash equivalents, beginning of period 818 515
Cash and cash equivalents, end of period $ 569 $ 3,224